Problem statement: Answer the multiple-choice question.
Query: Which compound exhibits a -24.695% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
(a) CCCCN(CC)CCNC(=O)c1cn(CCOC)c(=O)c2c1c1ccccc1n2C
(b) COc1ccc(C(=O)Nc2c(N)nc(SCC(=O)NCC3CCCO3)[nH]c2=O)cc1
Answer: a. CCCCN(CC)CCNC(=O)c1cn(CCOC)c(=O)c2c1c1ccccc1n2C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCCN(CC)CCNC(=O)c1cn(CCOC)c(=O)c2c1c1ccccc1n2C
CCCCN(CC)CCNC(=O)c1cn(CCOC)c(=O)c2c1c1ccccc1n2C
N-[2-[butyl(ethyl)amino]ethyl]-2-(2-methoxyethyl)-9-methyl-1-oxopyrido[3,4-b]indole-4-carboxamide